Explore more publications!

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on February 19, 2026

Global Respiratory Syncytial Virus (RSV) Vaccines Market to Reach $1.24 Billion by 2030 | MarketsandMarkets™
Bonafide® Health Launches Noctera™  – A Novel, Hormone-Free Supplement Designed to Improve Sleep Quality and Duration Negatively Impacted by Hormonal Changes
Klothea Bio Announces the Launch of a Phase 1b Clinical Trial of AKL003, an Alpha Klotho mRNA Therapeutic, for the Extension of Human Lifespan
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
Mapi Pharma to Host Virtual KOL Event to Discuss Glatiramer Acetate Once a Month Depot for Primary Progressive Multiple Sclerosis, on March 3, 2026
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth
Outlook Therapeutics Expands European Footprint with Exclusive Commercial Distribution Agreement with Mediconsult AG for LYTENAVA™ (bevacizumab gamma) in Switzerland
Just Salad Opens in Massapequa Park, New York
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”
Clene to Present at the Emerging Growth Conference
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
Wave Life Sciences Fourth Quarter and Full Year 2025 Financial Results Scheduled for February 26, 2026
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions